Dr. Su Ann Ding is currently completing her final year of endocrinology fellowship in NSW, Australia. Her research work has been focused on investigating the cardiometabolic effects of bariatric surgery (Roux-en-Y gastric bypass and gastric banding) as compared to intensive diabetes and weight loss management in obese patients with type 2 diabetes. She is also interested in exploring underlying pathophysiological mechanisms to explain weight independent glycemic improvements from bariatric surgery in obese patients with type 2 diabetes. During her research fellowship in Dr. Goldfine’s lab at Joslin Diabetes Center and Harvard Medical School, Boston, Dr. Ding completed a trial to compare bariatric surgery to an intensive multidisciplinary group diabetes and weight loss program. She also co-authored a chapter on metabolic surgery in the recent DeGroot Endocrine textbook.
Dr. Ding received her undergraduate degree in Basic Medical Sciences and her medical degree (Bachelor of Medicine and Bachelor of Surgery) from University of Nottingham, United Kingdom. Following completion of her endocrinology fellowship, she plans to further her career by pursuing a postgraduate higher degree and continuing her research work in understanding underlying pathophysiological mechanisms of the pathogenesis of type 2 diabetes in patients of different ethnicities, which in turn would enable optimization of glycemic control and T2D prevention in a more targeted manner for the different ethnic groups.